user avatar
David Braun
@BraunMDPhD
Oncologist, physician-scientist @YaleCancer @YaleMed | cancer immunotherapy, genomics, kidney cancer | tweets ≠ medical advice. ASCO FCOI:bit.ly/3Sv8P6A
Yale, New Haven, CT
thebraunlab.org
Joined April 2018
1,289
Following
3,689
Followers
Posts
  • Pinned
    user avatar
    David Braun
    @BraunMDPhD
    Jul 3, 2025
    1/ Recently, our lab has worked with outstanding groups (#TeamScience) to address some key questions in kidney cancer immunobiology: Can we use machine-learning approaches to classify RCC and predict response? @Cancer_Cell What drives exceptional response with immunotherapies?
    13K
  • user avatar
    David Braun
    @BraunMDPhD
    Jan 9, 2022
    Officially settling in here @YaleCancer @YaleMed, and I am grateful for the warm welcome! If you are interested in cancer immunotherapy, translational research, genomics, or kidney cancer, please contact me ([email protected]). We are hiring at all levels (postgrad, MS, PhD)!
  • user avatar
    David Braun
    @BraunMDPhD
    Dec 9, 2021
    An exciting but also a bit of a bittersweet announcement - after 8+ amazing years @BrighamMedRes @DanaFarber @harvardmed, I will be starting a new laboratory (thebraunlab.org) @YaleCancer @YaleMed on January 1, 2022 1/n
    thebraunlab.org
    BraunLab
  • user avatar
    David Braun
    @BraunMDPhD
    Mar 10, 2022
    Out in @NEJM this week, our perspective on some recent outstanding work defining the phenotype of tumor-infiltrating T cells across cancer types, and our thoughts on next steps. Tumor-Infiltrating T Cells — A Portrait | NEJM nejm.org/doi/full/10.10… @YaleCancer @YaleMed
    nejm.org
    Tumor-Infiltrating T Cells — A Portrait | NEJM
    Genetic landscaping and T cells are all the rage when it comes to tumor biology. Put them together and you get a comprehensive view of the T cell in the context of different types of cancer. The au...
  • user avatar
    David Braun
    @BraunMDPhD
    Mar 9, 2022
    And the BraunLab is officially up and running! It may just be culturing some cell lines today, but feels good to be at the bench again. Thanks to my right hand man Nick Schindler and all of the support from @YaleCancer @YaleMed
  • user avatar
    David Braun
    @BraunMDPhD
    Mar 11, 2021
    1/ Happy to share our latest work out today in @Cancer_Cell – a single-cell dissection of the kidney cancer immune microenvironment that uncovers important immune circuitry in advanced disease stages @DanaFarber @DanaFarberNews @harvardmed @broadinstitute
    Progressive immune dysfunction with advancing disease stage in renal cell carcinoma
    From cell.com
  • user avatar
    David Braun
    @BraunMDPhD
    Oct 20, 2022
    Great time chatting about cancer immunotherapy and the importance of physician-scientists with gold medalist @nathanwchen. Thanks for stopping by our lab! @YaleCancer @SmilowCancer @YaleMed
  • user avatar
    David Braun
    @BraunMDPhD
    May 29, 2020
    1/ Excited to share our work on genomic & immune determinants of anti-PD1 response in RCC, presented today #ASCO20 and published @NatureMedicine. Thanks to patients; mentors/collaborators #CathyWu, @DrChoueiri, @shuklasachet, @LabSignoretti, @VanAllenLab nature.com/articles/s4159…
  • user avatar
    David Braun
    @BraunMDPhD
    Nov 5, 2021
    A very nice overview of some of the differences between anti-CTLA-4 and anti-PD-1 therapies from Dr. Allison #IKCS2021
  • user avatar
    David Braun
    @BraunMDPhD
    Jul 19, 2023
    Very grateful to @theNCI and @CDMRP for the support to better understand and treat kidney cancer. Importantly, we are hiring postdocs/research scientists with expertise in experimental immunology. If you have extensive experience in immunology, please contact me!
    user avatar
    Yale Cancer Center
    @YaleCancer
    Jul 19, 2023
    Congratulations to the lab of @BraunMDPhD! The team has received approximately $5.75M in funding from @theNCI and @DeptofDefense to investigate the immune microenvironment of renal cell carcinoma. #RCC #kidneycancer #cancerresearch @YaleMed @SmilowCancer yalecancercenter.org/news-article/n…
    28K
  • user avatar
    David Braun
    @BraunMDPhD
    Jan 27, 2024
    Historic moment form @DrChoueiri , first adjuvant OS benefit in kidney cancer #GU24
    13K
  • user avatar
    David Braun
    @BraunMDPhD
    Feb 23, 2023
    Thank you @YaleCancer @YaleMed and all my past and present mentors for the support!
    user avatar
    Yale Cancer Center
    @YaleCancer
    Feb 23, 2023
    Congratulations to @BraunMDPhD, who has been awarded an American Society for Clinical Investigation (@the_asci) Young Physician-Scientist Award. Dr. Braun will attend the AAP/ASCI/APSA Joint Meeting in April. @SmilowCancer @YaleMed @YNHH
    19K
  • user avatar
    David Braun
    @BraunMDPhD
    Sep 15, 2022
    Very grateful to @KidneyCancer for the award, and to the amazing team (@Chrislabaki1 @LisaHenske @shuklasachet @VanAllenLab @DrChoueiri and others) as we try to better understand and treat this histology and beyond @YaleCancer @SmilowCancer
    user avatar
    Kidney Cancer
    @KidneyCancer
    Sep 15, 2022
    Replying to @KidneyCancer
    ⭐️Congratulations to KCA Trailblazer Award winner @BraunMDPhD @YaleCancer @YaleMed! His research will dissect the #immunobiology of #chromophobe #RCC using single-cell transcriptomics. #kidneycancer kidneycancer.org/2022-grants/
  • user avatar
    David Braun
    @BraunMDPhD
    Sep 20, 2024
    Thank you! I am very grateful, especially to receive anything in Dr. Wood's name. I will certainly do my best to try to honor his tremendous legacy @YaleCancer @YaleMed @Yale_Urology @yalepathology
    user avatar
    Kidney Cancer
    @KidneyCancer
    Sep 20, 2024
    🎉 Congratulations @BraunMDPhD recipient of the KCA’s Christopher G Wood Rising Star Award! Join us to celebrate at #IKCSNA24 Nov 7-9 in Louisville, KY! Early reg open through Oct 10: kidneycancer.org/ikcs/2024-ikcs…
    8.6K